Mar 29, 2012 - Mar 29, 2014
This activity, sponsored by the Johns Hopkins University School of Medicine, will discuss the pathophysiology and definition of spasticity to aide in patient evaluation, assess the usefulness and limitations of various scales used for evaluation, and describe available treatments and clinically relevant distinctions in dosing and bioavailability between chemodenervation agents that are available for the management of spasticity in adults and children to help clinicians improve patient quality of life. Approved for a maximum of 0.5 AMA PRA Category 1 Credit(s)™
Jul 13, 2012 - Jul 12, 2015
Fatigue is the most commonly reported symptom in persons with Multiple Sclerosis. Fatigue interferes with sustained usual function, and is a significant cause of loss of employment and disability in otherwise unimpaired persons with MS. Despite its prevalence, primary MS fatigue is often under recognized and treated in the MS population. This course includes information about the presentation and mechanisms of MS fatigue, as well as treatment strategies for both primary MS fatigue and contributing factors. Approved for 1.0 CME. Sponsored by AAN.
Dec 20, 2012 - Dec 20, 2013
Faculty: Andrew N. Wilner, MD; Robert P. Lisak, MD; Omar A. Khan, MD This activity is intended for neurologists, primary care physicians, physical medicine and rehabilitation specialists, nurse practitioners, physician assistants, and nurses. The goal of this activity is to discuss new data on disease-modifying therapies for treatment of multiple sclerosis (MS) presented at the 28th Congress of the European Committee for Treatment and Research in MS (ECTRIMS). Upon completion of this activity, participants will be able to: 1.Assess new safety and efficacy data on MS disease-modifying therapies 2.Describe how emerging MS treatments may be integrated into clinical practice 3.Determine the potential of meeting data on MS treatments to enhance treatment responses Physicians - maximum of 1.25 AMA PRA Category 1 Credit(s)™
Jan 07, 2013 - Jan 07, 2014
This Virtual Patient simulation resource utilizes advanced 3D real-time technology that responds to your clinical decisions as you build a clinically definite MS diagnosis for each of three patients according to the 2010 McDonald Criteria. This activity is designed for neurologists, nurse practitioners, physician assistants, and other healthcare professionals who care for patients with MS. Objectives: · Incorporate the 2010 McDonald MS Diagnostic criteria into your MS diagnostic process. · Recognize and utilize key features of the neurologic examination and patient’s history that support the diagnosis of MS. · Increase your ability to apply neuroimaging findings correlate with disease activity and progression in MS to enhance your clinical judgments and treatment decisions Continuing Education Credits: Physicians: 2.0 AMA PRA Category 1 Credits™. Physician Assistants: AMA PRA Category 1 Credit(s)™ Nurse Practitioners: AMA PRA Category 1 Credit(s)™
Mar 25, 2013 - Mar 25, 2014
The online formative assessment aims to provide clinicians with guidance from experts in the field, training to optimally assess the risks and benefits of MS therapies, and to enable the adoption of imaging and other instruments in their practice in order to better assess and manage patients with MS. Each of the five modules within this activity has their own learning objective. Upon completion of each of the modules, participants will be able to: •[Pathophysiology module]: Examine the basic tenets of MS immunology and recognize the scientific factors supporting the clinical management of MS •[Imaging assessment module]: Adopt improved diagnostic and assessment approaches in MS management that utilize advances in imaging technology and other screening tools •[Disease modification module]: Discuss the goals of MS treatment with patients; implement clinical algorithms for initial disease management and to improve outcomes •[Patient-centered care module]: Formulate and monitor treatment strategies for MS based on patient characteristics and preferences •[Symptom management]: Evaluate the safety and efficacy of pharmacologic treatment approaches for disease modification and symptom management Accredited for physicians and nurses. CME/CE accredited by module for physicians and nurses. SPonosred by COnsortium of MS Centers (CMSC)
May 15, 2013 - May 15, 2014
This educational activity is designed for physicians and other clinicians who manage and treat patients with MS. Bruce Cohen, MD, Chair. Upon completion of this activity, participants should be able to: •Examine the basic tenets of MS immunology and recognize the scientific factors supporting the clinical management of MS. •Adopt improved diagnostic and assessment approaches in MS management that utilize advances in imaging technology and other screening tools. •Discuss the goals of MS treatment with patients to implement clinical algorithms for initial disease management and improve outcomes. •Formulate and monitor treatment strategies for MS based on patient characteristics and preferences. •Evaluate the safety and efficacy of pharmacologic treatment approaches for disease modification and symptom management. This activity utilizes a digital platform that enables learners to explore three patient profiles (case-based learning) that present some of the challenges clinicians may encounter when treating patients with MS. It has been determined that this online activity can be completed in 45 minutes. 0.75 AMA PRA Category 1 Credit
May 22, 2013 - May 22, 2014
This 5-session series of webinars for OTs and PTs provides rehabilitation professionals with updated information on the diagnosis and treatment of MS and evidence-based rehabilitation management. The five topics covered are: - MS 101 - Spasticity and MS - Electrical Stimulation - Pain Management - Focus on OT. Each 1 hour webinar is approved for 1 hour continuing education credit in OK, AR, NM and TX. Free with discount code: NMSSOFF
Jun 27, 2013 - Jun 27, 2014
On-demand webinar: Join Dr. Kottil Rammohan and a distinguished panel of experts for an expert review on the assessment of MS-related cognitive impairment, the role of neuroimaging in diagnosis and monitoring, and the potential impact of disease modifying therapies on improving cognition. This activity is based on the proceedings from a live interactive workshop held with MS clinical team members. This edited version contains highlights from the live workshop and includes a comprehensive recap of the latest evidence in the area of cognitive impairment in MS. The program features synchronized expert audio and slide presentations and downloadable clinical tools. CMSC designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. This enduring material is awarded 1.0 contact hours of continuing education credit for nurses and advanced practice nurses.
Jul 12, 2013 - Jul 11, 2014
On-demand: South Texas Regional Family Practice Grand Rounds by Dr. Rebecca Romero. Co-sponsored by UT Health Sciences Center and the South Rexas Regional Area Health Education Center (AHEC.) Approved for 1 CME credit.
Jul 15, 2013 - May 30, 2014
The goal of the series is to provide practical clinical information to neurologists and other health care providers involved in the care of patients with Multiple Sclerosis (MS). Topics include: •The Changing View of Immunopathology in MS Treatment Edward J. Fox, MD, PhD •Hot Topics in MS: Environmental and Genetic Influences Edward J. Fox, MD, PhD •Current Treatment Options for MS: Personalized Medicine Strategies Bruce A. Cree, MD, PhD •Principles of MS Treatment Bruce A. Cree, MD, PhD •Strategies to Identify and Address Barriers to Patient Adherence to MS Therapies Lori L. Mayer, RN, MSN, MSCN, CCRP Physicians The Consortium of Multiple Sclerosis Centers (CMSC) designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Nurses Nurse Practitioner Alternatives awards 0.5 contact hours of continuing nursing education for RNs and APRNs.
Jul 30, 2013 - Jul 30, 2014
MS is a chronic, progressive, inflammatory, and neurodegenerative disease of the central nervous system that leads to significant disability. The push towards ever earlier diagnosis and treatment of MS and the rapid emergence of novel agents are causing considerable changes to the management of the disease. The decisions regarding when to initiate treatment and which agents to use, along with deliberations on long-term management, are all increasingly difficult, with adherence issues continuing to negatively impact outcomes and add to the intricacy of MS treatment. The emerging data on biomarker research, aimed at increasing diagnostic accuracy and aiding in management, adds to the complexity of decision-making in MS. This program provides neurologists and MS specialists with updates on the latest advances in MS diagnosis and management, so that they can optimize outcomes for their patients with MS. Faculty: SUHAYL DHIB-JALBUT, MD; CLYDE E. MARKOWITZ, MD; AARON E. MILLER, MD Physicians – 1.25 AMA PRA Category 1 credit(s)™. Nurses – 1.25 contact hours.
Jul 31, 2013 - Jul 31, 2014
Utilizing an audience interactive format together with clinician-patient video vignettes and expert faculty presentations, dialogue and commentary, this case-based program will address: evaluation tools used to assess patient mobility status early in MS and throughout the disease progression; how to implement enhanced communication and education skills to empower patients and caregivers to engage in shared decision-making; and, nonpharmacological and pharmacological approaches to improve symptoms that limit patient mobility. This CME/CE activity was originally presented on Wednesday, May 29, 2013, in Orlando, Florida, in conjunction with the Fifth Cooperative Meeting of the Consortium of MS Centers (CMSC) and the Americas Committee for Treatment and Research in MS (ACTRIMS), and was adapted for release on July 31, 2013. Content was developed by faculty. The symposium was supported by an educational grant from Acorda Therapeutics, Inc. Physicians - maximum of 1.5 AMA PRA Category 1 Credit(s)TM. Nurses - 1.5 contact hours. All other healthcare professionals completing this activity will be issued a certificate of participation.
Aug 13, 2013 - May 19, 2014
Advances in the Assessment and Management of Multiple Sclerosis; At the conclusion of this activity, participants will be able to: • Assess and apply recent clinical guidelines, emerging evidence, and current expert opinion to improve the differential diagnosis of multiple sclerosis (MS); • Choose among currently approved disease-modifying therapies for MS patients based on patient characteristics and recent clinical evidence, and outline the potential role of novel therapies currently in development; • Understand the significance and utility of emerging diagnostic and prognostic biomarkers for MS in order to appropriately apply them in clinical practice; • Identify common reasons for suboptimal patient adherence to disease-modifying therapies and apply strategies to improve adherence to treatment; • Develop evidence-based, expert-driven management plans for MS symptoms that improve functional abilities and quality of life for patients with MS . The summit is planned to meet the continuing medical education needs of neurologists involved in the diagnosis, treatment and ongoing management of patients with MS. Additionally, general neurologists, internists, family physicians, nurse practitioners, physician assistants, and pharmacists who are actively engaged in the care of patients with MS may also benefit from participating in the program as secondary audiences. The Northwestern University Feinberg School of Medicine designates this enduring material for a maximum of 6.0 AMA PRA Category 1 Credit(s)™. American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credit™ .. American Academy of Nurse Practitioners (AANP) accepts AMA PRA Category 1 Credit™ . American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™. No fee.
Aug 21, 2013 - Aug 21, 2014
The intended audience for this activity is neurologists, neurology nurses, pharmacists and other healthcare professionals involved in the treatment of patients with multiple sclerosis. At the conclusion of this activity participants should be able to: • Assess patient and medication-related factors which may affect patient adherence and persistence to treatment for multiple sclerosis. • Incorporate management strategies that reduce relapses of relapsing-remitting multiple sclerosis and improve adherence to interferon-beta therapies to minimize negative impacts on patients. • Employ individualized patient management programs, education and support to improve adherence to multiple sclerosis therapy. Faculty: Guy J. Buckle, MD, MPH, Chair; Aaron Boster, MD; Patricia Kennedy, RN, CNP, MSCN; Lynn Stazzone RN, MSN, NP, MSCN This program is acceptable for 1.5 contact hours of ACPE Continuing Education Credit.
Oct 24, 2013 - Nov 24, 2014
The complexity of MS patient management is increasing dramatically, based on the growth of novel disease modifying therapy options. One of the most challenging issues to face neurologists in the coming years is the integration of these newer therapies into their clinical armamentarium. This patient centered CME/CNE program allows MS treating clinicians to learn in the context of actual MS patients. With new disease modifying therapies available and emerging, there is a unique opportunity to provide educational experiences in the context of real world referrals that can alter long-term practice patterns. This activity is intended for healthcare professionals, specifically, neurologists, internists, family practice physicians, nurse practitioners, physician assistants, registered nurses and other providers involved in the care of patients with multiple sclerosis.The University of Texas Southwestern Medical Center designates this enduring material for a maximum of 0.50 AMA PRA Category 1 CreditTM. This educational activity for 0.5 contact hours is provided for nurses by Postgraduate Institute for Medicine. No fee.
Dec 09, 2013 - Dec 08, 2014
Two MS patients describe their struggles with ongoing disease activity and a succession of therapies. Among the management challenges are disability and serious side effects, notably PML.The interactive video program features Patricia Kennedy, RN, CNP, MSCN, and Clyde Markowitz, MD. 1.5 AMA PRA Category 1 Credits. No fee.
Feb 07, 2014 - Feb 09, 2015
ISNVD offers physicians, scientists, and health care providers of all types the opportunity to learn recent advances in development of research options for neurovascular disorders, and an opportunity to contribute to these ideas. The International Society for NeuroVascular Disease is a non-profit professional association devoted to furthering the development of research for neurovascular related diseases. Complete Conference Management designates this live activity for a maximum of 11.75 AMA PRA Category 1 CreditsTM. $460.